News for Healthier Living

Decitabine Induces irf7-Mediated Immune Responses in p53-Mutated Triple-Negative Breast Cancer: A Clinical and Translational Study

The findings of this research reveal the potential of repurposing decitabine for the treatment of p53-mutated TNBC and suggest IRF7 as a potential biomarker for decitabine-based treatments.

October 31, 2025


November 5 2025

November 4 2025

November 3 2025

November 2 2025

November 1 2025

October 31 2025

October 30 2025

October 29 2025

October 28 2025

October 27 2025

October 26 2025

October 25 2025

October 24 2025

October 23 2025